BeiGene
BGNE
Company News
2022-10-06 20:55
U.S.-listed Chinese firms trade lower_china.org.cn - China.org.cn
2022-10-05 17:00
Metastatic Renal Cell Carcinoma Clinical Trials Pipeline Landscape Analysis of 45+ Companies by DelveInsight - GlobeNewswire
08:10
Partner insight: China emerges as a new player in biotech - Investment Week
2022-10-04 21:11
U.S.-listed Chinese firms trade higher_china.org.cn - China.org.cn
21:11
U.S.-listed Chinese firms trade higher - China.org.cn
2022-09-30 20:33
Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Prognostic and More - ASCO Journals
2022-09-29 20:58
U.S.-listed Chinese firms trade lower_china.org.cn - China.org.cn
18:31
Latest Push by Chinese Firms to Avoid Delistings Falls Short - Yahoo Finance
16:15
BeiGene Becomes Oversold (BGNE) - Nasdaq
00:51
Tracking Baker Brothers Portfolio – Q2 2022 Update - Seeking Alpha
2022-09-28 17:08
Chinese Private Equity Firm Hillhouse Launches “Aseed+” Early-Stage Fund - Pandaily
2022-09-27 21:46
U.S.-listed Chinese firms trade flat_china.org.cn - China.org.cn
01:26
U.S.-listed Chinese firms trade mostly higher_china.org.cn - China.org.cn
2022-09-26 21:39
Despite slow regulatory activity, NME approvals pick up in September - BioWorld Online
2022-09-25 12:40
Co-Founder John Oyler Just Sold A Bunch Of Shares In BeiGene, Ltd. (NASDAQ:BGNE) - Simply Wall St
2022-09-23 00:15
BeiGene, Ltd. (NASDAQ:BGNE) CEO Sells $4684820.00 in Stock - MarketBeat
Market Basic
Loading
Stock Chart
Loading DAILY data...
Team
BGNE Core
John V. Oyler - Co-Founder, Exec. Chairman | CEO
Dr. Xiaobin Wu Ph.D. - Pres, COO | GM of China
Dr. Xiaodong Wang Ph.D. - Co-Founder, Chairman of the Scientific Advisory Board | Non-Exec. Director
John V. Oyler - Co-Founder, Exec. Chairman | CEO
Dr. Xiaobin Wu Ph.D. - Pres, COO | GM of China
Dr. Xiaodong Wang Ph.D. - Co-Founder, Chairman of the Scientific Advisory Board | Non-Exec. Director
to get more data
Financial Report
Financing Record
to get more data
Investment Record